December 2021—Roche has launched the Avenio Tumor Tissue Comprehensive Genomic Profiling Kit, complementing the current CGP portfolio offered by Roche and Foundation Medicine.
Read More »December 2021—Roche has launched the Avenio Tumor Tissue Comprehensive Genomic Profiling Kit, complementing the current CGP portfolio offered by Roche and Foundation Medicine.
Read More »